| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 05/31/2005 | US6900035 Comprises human papilloma virus (HPV) fusion between mycobacterial chaperone protein and viral E6 protein for use in treating tumors |
| 05/26/2005 | WO2005047338A1 Cancer cell targeting gene delivery method |
| 05/26/2005 | WO2005047337A1 A pharmaceutical composition comprising an immunoglobulin fc region as a carrier |
| 05/26/2005 | WO2005047336A1 Protein complex using immunoglobulin fragment andmethod for the preparation thereof |
| 05/26/2005 | WO2005047335A1 Method for themass production of immunoglobulin constant region |
| 05/26/2005 | WO2005047334A1 Igg fc fragment for a drug carrier and method for the preparation thereof |
| 05/26/2005 | WO2005012336A3 Uranium-chelating peptides and uses thereof |
| 05/26/2005 | US20050113284 Drug for regenerating tissue and vessel and method therefor |
| 05/26/2005 | US20050113273 Alkaline protease from bacillus gibsonii (DSM 14393) and washing and cleaning products comprising said alkaline protease |
| 05/26/2005 | US20050112744 Glucose dehydrogenase fusion proteins and their use in expression systems |
| 05/26/2005 | US20050112725 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/26/2005 | US20050112721 Chimeric peptide immunogens |
| 05/26/2005 | US20050112682 Green fluorescent fusion protein as diagnosis tool; quantitative analysis; colorimetic analysis |
| 05/26/2005 | US20050112565 Proteases |
| 05/26/2005 | US20050112134 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease |
| 05/26/2005 | US20050112117 Molecules and methods for inhibiting shedding of KIM-1 |
| 05/26/2005 | CA2544308A1 Cytokine antagonist molecules |
| 05/26/2005 | CA2512657A1 Protein complex using immunoglobulin fragment and method for the preparation thereof |
| 05/25/2005 | EP1532251A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use |
| 05/25/2005 | EP1532239A2 Methods and compositions for targeting secretory lysosomes |
| 05/25/2005 | EP1532177A2 Immunomodulatory constructs and their uses |
| 05/25/2005 | EP1532174A2 Anti-igf-i receptor antibody |
| 05/25/2005 | EP1531858A2 Immunogenic composition comprising a fusion protein and a saponin adjuvant |
| 05/25/2005 | EP1531848A2 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 05/25/2005 | CN1620510A Cytokine protein family |
| 05/25/2005 | CN1618977A Method of revealing target protein on cell surface using bactospein S layer protein as carrier and application thereof |
| 05/25/2005 | CN1618814A Method of diagnosing and treating heritage spasm paraplegia using NIPAl gene mutation hot point |
| 05/25/2005 | CN1618811A Cell surface molecule mediating cell adhesion and signal transmission |
| 05/25/2005 | CN1618802A Tetramer combined with SARS antigen peptide and its preparation and use |
| 05/25/2005 | CN1203178C Multivalent antigen-binding proteins |
| 05/25/2005 | CN1202862C Compsns. comprising comjugates of stable, active, human OB protein with antibody Fc chain and methods |
| 05/24/2005 | US6897294 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 05/24/2005 | US6897292 For detecting a genetic abnormality, cancer |
| 05/24/2005 | US6897043 Nucleotide sequences for use as efficient gene transfer and cloning tool in genetic engineering |
| 05/24/2005 | US6897039 For treatment of cardiovascular diseases. |
| 05/24/2005 | US6896887 Binding of a proteinaceous substance to cell-wall material of a Gram-positive bacterium |
| 05/24/2005 | CA2123875C Hepatitis-c virus testing |
| 05/24/2005 | CA2037607C Humanised antibodies |
| 05/19/2005 | WO2005017093A8 Polypeptides of streptococcus pyogenes |
| 05/19/2005 | WO2004111075A8 Alternative reading frame polypeptides for treatment |
| 05/19/2005 | WO2004106378A3 Method of treating corneal transplant rejection by using vegf antagonists |
| 05/19/2005 | WO2003029419A3 Three dimensional structure of crystalline grp94 binding domain, and its methods of use |
| 05/19/2005 | WO2003009815A3 Compositions and methods for modulating blood-brain barrier transport |
| 05/19/2005 | US20050107601 Nucleotide sequences coding immunoglobulin fusion specific to heparan sulfate proteoglycans for use as diagnostic and therapeutic tool in treatment and prevention of neurodegenerative and cell proliferative disorders |
| 05/19/2005 | US20050107597 Nucleotide sequences coding microorganismal secondary response gene (SPA-1) for as tool in diagnosis, prevention and treatment of pseudomonal infection |
| 05/19/2005 | US20050107592 Lipid binding protein 1 |
| 05/19/2005 | US20050107589 Membrane fusion protein for use as toole in the treatment and prevention of inflammatory bowel and autoimmune diseases |
| 05/19/2005 | US20050107585 Signal-1/signal-2 bifunctional peptide inhibitors |
| 05/19/2005 | US20050107256 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 05/19/2005 | US20050106695 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 05/19/2005 | US20050106659 Membrane protein for use as tool in detection of modulators for diagnosis, prevention and treatment of neurological and/or psychiatric diseases |
| 05/19/2005 | US20050106601 Transgenic mouse whose somatic and germ cells express an Fkhsf transgene and mutants; immunomodulators |
| 05/19/2005 | US20050106154 GASP1: a follistatin domain containing protein |
| 05/19/2005 | US20050106148 Method of treating blood disorders |
| 05/19/2005 | US20050106099 Fusion proteins |
| 05/19/2005 | CA2545166A1 Humanized anti-cd47 antibody |
| 05/19/2005 | CA2544214A1 Hla-dr-binding antigen peptide derived from wt1 |
| 05/18/2005 | EP1530630A2 Novel lipases and uses thereof |
| 05/18/2005 | CN1617732A Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 05/18/2005 | CN1616491A Fusion protein with cold proventing and curing function and its encoding gene and use |
| 05/18/2005 | CN1616490A Fusion protein of protein A function structure domain-fluorescent protein and its constructing method |
| 05/18/2005 | CN1616117A Trans genetically synthetic human type I collagen fusion protein nerve substrate film as bionic material |
| 05/18/2005 | CN1202248C Flat-chin sea snake long-chain neurotoxin gene and its expression and application |
| 05/18/2005 | CN1202247C Chimeric heteromultimer adhesins |
| 05/18/2005 | CN1201819C Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 05/18/2005 | CN1201818C Vaccine |
| 05/17/2005 | US6894157 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 05/12/2005 | US20050101773 Genes required for viability and/or reproduction in c. elegans and their use in the development of anti-nematode agents |
| 05/12/2005 | US20050100987 Using ribonucleoside diphosphate reductase intein as tool to generate preferential amino terminal protein fusion; directed protein evolution |
| 05/12/2005 | US20050100984 Expression vector comprising nucleotide sequences coding immunoglobulin fusion directed towards tumors for use in treatment and prevention of cell proliferative disorders; tissue targeted therapy; immunotherapy |
| 05/12/2005 | US20050100970 Method of affinity separation and ligands for use therein |
| 05/12/2005 | US20050100918 Mammalian receptor proteins; related reagents and methods |
| 05/12/2005 | US20050100917 Mammalian receptor proteins; related reagents and methods |
| 05/12/2005 | US20050100894 Novel mitogen activated kinase |
| 05/11/2005 | EP1529845A2 Fusion glycoprotein from HCMV and HSV |
| 05/11/2005 | EP1529109A2 Production of multimeric fusion proteins using a c4bp scaffold |
| 05/11/2005 | EP1529108A2 Albumin-fused ciliary neurotrophic factor |
| 05/11/2005 | EP1529064A2 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 05/11/2005 | EP1248802B9 Soluble ctla4 mutant molecules and uses thereof |
| 05/11/2005 | EP0730606B1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
| 05/11/2005 | EP0625200B1 Biosynthetic binding protein for cancer marker |
| 05/11/2005 | CN1613873A Anti-cancer surface antigen of p185 monoantigen embedded antibody and its preparation |
| 05/11/2005 | CN1201011C Heterologous expression of neisserial proteins |
| 05/11/2005 | CN1201004C HER-2/neu fusion proteins |
| 05/11/2005 | CN1201003C Adipocyte-specific protein homologs |
| 05/10/2005 | CA2116559C Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
| 05/10/2005 | CA1341482C Process for preparing fragments of aids-associated retroviruses |
| 05/06/2005 | WO2005040386A2 A vector modification for versatile use of expressed products |
| 05/05/2005 | US20050096460 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same |
| 05/05/2005 | US20050096457 Peptide substrates and fusion polypeptide substrates comprising a beta -secretase cleavage site wherein a human Aspartyl protease cleaves the peptide between P1 and P1, the rate of which cleavage is used to identify modulators of Alzeimer's disease, neurofibrillary tangles, gliosis and neuronal loss |
| 05/05/2005 | US20050096277 Methods of prevention and treatment using apolipoprotein analogues |
| 05/05/2005 | US20050096271 Fusion of polypeptides and immunoglobulin protein; immunotherapy ; antiallergens; antiarthritic agents; anticancer agents; antiinflammatory agents |
| 05/05/2005 | US20050095258 Vaccine inhibiting gonadotropin releasing hormone activity in cattle and protecting against bovine herpes virus type 1; polynucleotides, vectors, transformed cells |
| 05/04/2005 | EP1528102A2 Cloning and recombinant productions of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 05/04/2005 | EP1527100A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 05/04/2005 | EP1364212A4 Three hybrid assay system |
| 05/04/2005 | EP1362062B1 Concatameric immunoadhesion |
| 05/04/2005 | EP0835266B1 Modified/chimeric superantigens and their use |
| 05/04/2005 | CN1613011A Signal system and elements used therein |
| 05/04/2005 | CN1612896A Peptide purification by means of metal ion affinity chromatography |